Novonesis (Novozymes) A/S - Asset Resilience Ratio
Novonesis (Novozymes) A/S (NSIS-B) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Novonesis (Novozymes) A/S's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Novonesis (Novozymes) A/S to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Novonesis (Novozymes) A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Novonesis (Novozymes) A/S market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0% |
| Short-term Investments | Dkr2.20 Million | 0.01% |
| Total Liquid Assets | Dkr2.20 Million | 0.01% |
Asset Resilience Insights
- Limited Liquidity: Novonesis (Novozymes) A/S maintains only 0.01% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Novonesis (Novozymes) A/S Industry Peers by Asset Resilience Ratio
Compare Novonesis (Novozymes) A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Xi'an Manareco New Materials Co.Ltd
SHG:688550 |
Specialty Chemicals | 11.24% |
|
EMS-CHEMIE HOLDING AG
SW:EMSN |
Specialty Chemicals | 28.01% |
|
Zhejiang Satellite Petrochemical Co Ltd
SHE:002648 |
Specialty Chemicals | 0.27% |
|
Shanghai Putailai New Energy Technology Co.Ltd.
SHG:603659 |
Specialty Chemicals | 9.06% |
|
Zhejiang Longsheng Group Co Ltd
SHG:600352 |
Specialty Chemicals | 0.80% |
|
Jiangsu Nata Opto Electr Material
SHE:300346 |
Specialty Chemicals | 22.39% |
|
Lily Group Co Ltd
SHG:603823 |
Specialty Chemicals | 0.37% |
|
Luxi Chemical Group Co Ltd
SHE:000830 |
Specialty Chemicals | 0.43% |
Annual Asset Resilience Ratio for Novonesis (Novozymes) A/S (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Novonesis (Novozymes) A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.12% | Dkr20.30 Million ≈ $3.18 Million |
Dkr16.35 Billion ≈ $2.56 Billion |
+0.10pp |
| 2024-12-31 | 0.03% | Dkr4.00 Million ≈ $625.83K |
Dkr15.20 Billion ≈ $2.38 Billion |
-0.11pp |
| 2023-12-31 | 0.14% | Dkr40.00 Million ≈ $6.26 Million |
Dkr28.39 Billion ≈ $4.44 Billion |
-0.14pp |
| 2022-12-31 | 0.29% | Dkr80.00 Million ≈ $12.52 Million |
Dkr27.98 Billion ≈ $4.38 Billion |
-0.02pp |
| 2021-12-31 | 0.30% | Dkr75.00 Million ≈ $11.73 Million |
Dkr24.77 Billion ≈ $3.87 Billion |
-0.28pp |
| 2020-12-31 | 0.58% | Dkr119.00 Million ≈ $18.62 Million |
Dkr20.51 Billion ≈ $3.21 Billion |
+0.51pp |
| 2019-12-31 | 0.07% | Dkr15.00 Million ≈ $2.35 Million |
Dkr20.44 Billion ≈ $3.20 Billion |
+0.00pp |
| 2018-12-31 | 0.07% | Dkr14.00 Million ≈ $2.19 Million |
Dkr19.70 Billion ≈ $3.08 Billion |
-0.02pp |
| 2017-12-31 | 0.09% | Dkr16.00 Million ≈ $2.50 Million |
Dkr18.37 Billion ≈ $2.87 Billion |
+0.07pp |
| 2016-12-31 | 0.02% | Dkr4.00 Million ≈ $625.83K |
Dkr18.66 Billion ≈ $2.92 Billion |
-0.09pp |
| 2015-12-31 | 0.11% | Dkr20.00 Million ≈ $3.13 Million |
Dkr17.79 Billion ≈ $2.78 Billion |
+0.02pp |
| 2014-12-31 | 0.09% | Dkr17.00 Million ≈ $2.66 Million |
Dkr18.43 Billion ≈ $2.88 Billion |
-0.43pp |
| 2013-12-31 | 0.53% | Dkr87.00 Million ≈ $13.61 Million |
Dkr16.51 Billion ≈ $2.58 Billion |
+0.23pp |
| 2012-12-31 | 0.30% | Dkr45.00 Million ≈ $7.04 Million |
Dkr15.11 Billion ≈ $2.36 Billion |
-0.05pp |
| 2011-12-31 | 0.35% | Dkr48.00 Million ≈ $7.51 Million |
Dkr13.84 Billion ≈ $2.17 Billion |
-1.07pp |
| 2010-12-31 | 1.41% | Dkr178.00 Million ≈ $27.85 Million |
Dkr12.59 Billion ≈ $1.97 Billion |
-0.81pp |
| 2006-12-31 | 2.22% | Dkr177.00 Million ≈ $27.69 Million |
Dkr7.96 Billion ≈ $1.25 Billion |
+0.16pp |
| 2005-12-31 | 2.07% | Dkr151.00 Million ≈ $23.63 Million |
Dkr7.31 Billion ≈ $1.14 Billion |
+0.76pp |
| 2004-12-31 | 1.30% | Dkr93.00 Million ≈ $14.55 Million |
Dkr7.13 Billion ≈ $1.12 Billion |
-0.20pp |
| 2003-12-31 | 1.51% | Dkr115.00 Million ≈ $17.99 Million |
Dkr7.63 Billion ≈ $1.19 Billion |
-0.48pp |
| 2002-12-31 | 1.99% | Dkr166.00 Million ≈ $25.97 Million |
Dkr8.35 Billion ≈ $1.31 Billion |
-- |
About Novonesis (Novozymes) A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The c… Read more